Michael Yaron
Concepts (613)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sjogren's Syndrome | 17 | 2001 | 40 | 1.970 |
Why?
| Arthritis, Rheumatoid | 44 | 2006 | 985 | 1.760 |
Why?
| Altitude Sickness | 9 | 2015 | 163 | 1.320 |
Why?
| Methotrexate | 15 | 1997 | 227 | 0.970 |
Why?
| Synovial Membrane | 10 | 2003 | 71 | 0.960 |
Why?
| Osteoarthritis | 12 | 2003 | 184 | 0.940 |
Why?
| Saliva | 7 | 2001 | 215 | 0.920 |
Why?
| Interleukin-1 | 11 | 2004 | 987 | 0.820 |
Why?
| Hyaluronic Acid | 12 | 2001 | 203 | 0.810 |
Why?
| Balneology | 4 | 2000 | 4 | 0.550 |
Why?
| Antibodies, Antinuclear | 7 | 2001 | 59 | 0.540 |
Why?
| Interleukin-6 | 6 | 2006 | 702 | 0.510 |
Why?
| Middle Aged | 86 | 2015 | 28563 | 0.500 |
Why?
| Surveys and Questionnaires | 7 | 2010 | 4882 | 0.490 |
Why?
| Calcium, Dietary | 1 | 2014 | 55 | 0.480 |
Why?
| Communication Barriers | 2 | 2007 | 92 | 0.470 |
Why?
| Endothelium | 1 | 2014 | 121 | 0.460 |
Why?
| Female | 114 | 2015 | 63629 | 0.460 |
Why?
| Arthritis, Psoriatic | 5 | 2000 | 16 | 0.440 |
Why?
| Fibromyalgia | 4 | 2009 | 58 | 0.430 |
Why?
| Nitric Oxide | 4 | 2003 | 884 | 0.430 |
Why?
| Altitude | 5 | 2004 | 425 | 0.430 |
Why?
| Arteries | 1 | 2014 | 256 | 0.420 |
Why?
| Humans | 153 | 2015 | 122796 | 0.410 |
Why?
| Male | 90 | 2015 | 59639 | 0.400 |
Why?
| Low Back Pain | 3 | 1998 | 103 | 0.390 |
Why?
| Adult | 72 | 2015 | 32385 | 0.390 |
Why?
| Aged | 55 | 2015 | 20495 | 0.390 |
Why?
| Rheumatic Diseases | 2 | 2010 | 49 | 0.380 |
Why?
| Dietary Supplements | 1 | 2014 | 473 | 0.370 |
Why?
| Medical Order Entry Systems | 1 | 2010 | 43 | 0.360 |
Why?
| Gold | 6 | 1997 | 106 | 0.340 |
Why?
| Travel | 2 | 2008 | 124 | 0.340 |
Why?
| Israel | 11 | 2010 | 38 | 0.340 |
Why?
| Prostaglandins E | 6 | 1993 | 47 | 0.330 |
Why?
| Aurothioglucose | 3 | 1997 | 6 | 0.320 |
Why?
| Physical Examination | 3 | 2015 | 253 | 0.320 |
Why?
| Antirheumatic Agents | 5 | 2006 | 254 | 0.320 |
Why?
| Drug Eruptions | 3 | 1997 | 28 | 0.320 |
Why?
| Spondylitis, Ankylosing | 4 | 2007 | 44 | 0.310 |
Why?
| Knee Joint | 5 | 2003 | 366 | 0.300 |
Why?
| Matrix Metalloproteinase 3 | 2 | 2006 | 22 | 0.300 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2003 | 302 | 0.300 |
Why?
| Severity of Illness Index | 4 | 2007 | 2784 | 0.290 |
Why?
| Sleep Wake Disorders | 2 | 2004 | 289 | 0.290 |
Why?
| Child Behavior | 2 | 2007 | 238 | 0.290 |
Why?
| Professional-Family Relations | 1 | 2008 | 141 | 0.280 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2004 | 1181 | 0.280 |
Why?
| Penicillamine | 5 | 1991 | 24 | 0.280 |
Why?
| Wilderness | 2 | 2015 | 17 | 0.270 |
Why?
| Child Welfare | 1 | 2008 | 201 | 0.270 |
Why?
| Lupus Erythematosus, Systemic | 9 | 2003 | 235 | 0.260 |
Why?
| Receptors, Interleukin-2 | 3 | 2000 | 73 | 0.260 |
Why?
| Length of Stay | 1 | 2010 | 1077 | 0.260 |
Why?
| Health Education | 1 | 2008 | 332 | 0.250 |
Why?
| Sensitivity and Specificity | 7 | 2010 | 1855 | 0.250 |
Why?
| Heat Stroke | 1 | 2004 | 6 | 0.240 |
Why?
| Tomography, X-Ray Computed | 8 | 1998 | 2500 | 0.240 |
Why?
| Emergency Service, Hospital | 3 | 2010 | 1922 | 0.240 |
Why?
| Hydroxybutyrates | 1 | 2003 | 11 | 0.230 |
Why?
| Phytotherapy | 1 | 2003 | 72 | 0.230 |
Why?
| Population Surveillance | 1 | 2007 | 439 | 0.230 |
Why?
| Osteoarthritis, Knee | 2 | 2003 | 225 | 0.230 |
Why?
| Aniline Compounds | 1 | 2003 | 71 | 0.230 |
Why?
| Anthraquinones | 2 | 2000 | 9 | 0.230 |
Why?
| Cervical Vertebrae | 2 | 1995 | 119 | 0.220 |
Why?
| Prednisone | 8 | 2003 | 234 | 0.220 |
Why?
| Fibroblasts | 7 | 1993 | 846 | 0.220 |
Why?
| Osteonecrosis | 2 | 1996 | 21 | 0.220 |
Why?
| Mud Therapy | 3 | 2000 | 3 | 0.210 |
Why?
| Respiration | 1 | 2003 | 189 | 0.210 |
Why?
| Plant Extracts | 1 | 2003 | 169 | 0.210 |
Why?
| Receptors, Interleukin-1 | 2 | 2001 | 230 | 0.210 |
Why?
| Dinoprostone | 2 | 1999 | 193 | 0.200 |
Why?
| Hydroxychloroquine | 2 | 1999 | 58 | 0.200 |
Why?
| Minocycline | 5 | 1999 | 29 | 0.200 |
Why?
| Wounds and Injuries | 5 | 2015 | 813 | 0.200 |
Why?
| Guanidines | 1 | 2001 | 38 | 0.200 |
Why?
| Prospective Studies | 15 | 2004 | 6704 | 0.200 |
Why?
| Retinal Hemorrhage | 1 | 2001 | 20 | 0.200 |
Why?
| Back Pain | 3 | 2000 | 45 | 0.190 |
Why?
| Hand | 5 | 2001 | 139 | 0.190 |
Why?
| Arthritis, Juvenile | 2 | 1992 | 42 | 0.190 |
Why?
| Pulmonary Edema | 1 | 2001 | 141 | 0.190 |
Why?
| Nitric Oxide Synthase | 1 | 2001 | 227 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 4 | 2014 | 1981 | 0.180 |
Why?
| Amitriptyline | 1 | 1999 | 24 | 0.180 |
Why?
| Synovial Fluid | 2 | 1989 | 57 | 0.180 |
Why?
| Emergency Treatment | 2 | 2004 | 117 | 0.180 |
Why?
| Fluoxetine | 1 | 1999 | 47 | 0.180 |
Why?
| Adrenal Cortex Hormones | 3 | 1999 | 515 | 0.180 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 1213 | 0.170 |
Why?
| Aged, 80 and over | 13 | 2010 | 6845 | 0.170 |
Why?
| Tears | 1 | 1998 | 14 | 0.170 |
Why?
| Resuscitation | 2 | 1994 | 279 | 0.170 |
Why?
| Calcinosis | 3 | 1998 | 292 | 0.170 |
Why?
| Immunosuppressive Agents | 1 | 2003 | 687 | 0.170 |
Why?
| Biomarkers | 12 | 2000 | 3662 | 0.170 |
Why?
| Analgesia, Epidural | 1 | 1998 | 20 | 0.170 |
Why?
| Antiphospholipid Syndrome | 2 | 1998 | 29 | 0.170 |
Why?
| Eye Proteins | 1 | 1998 | 77 | 0.170 |
Why?
| Down-Regulation | 1 | 2001 | 654 | 0.160 |
Why?
| Cross-Over Studies | 2 | 2014 | 469 | 0.160 |
Why?
| Disasters | 1 | 1999 | 90 | 0.160 |
Why?
| Pain Measurement | 5 | 2004 | 481 | 0.150 |
Why?
| Osteoporosis | 2 | 1999 | 234 | 0.150 |
Why?
| Hypoxia | 1 | 2004 | 1003 | 0.150 |
Why?
| Acute Disease | 6 | 2007 | 984 | 0.150 |
Why?
| Enzyme Inhibitors | 1 | 2001 | 836 | 0.150 |
Why?
| RNA, Small Cytoplasmic | 1 | 1997 | 8 | 0.150 |
Why?
| Bronchial Spasm | 1 | 1996 | 8 | 0.150 |
Why?
| Capnography | 1 | 1996 | 12 | 0.150 |
Why?
| Antibodies, Antiphospholipid | 1 | 1996 | 23 | 0.150 |
Why?
| Anti-Inflammatory Agents | 4 | 2003 | 469 | 0.140 |
Why?
| Mortality | 1 | 1999 | 317 | 0.140 |
Why?
| Sulfasalazine | 2 | 1997 | 21 | 0.140 |
Why?
| Ultraviolet Rays | 1 | 2000 | 413 | 0.140 |
Why?
| Disabled Persons | 2 | 2015 | 154 | 0.140 |
Why?
| C-Reactive Protein | 5 | 1999 | 363 | 0.140 |
Why?
| Rheumatoid Nodule | 3 | 2001 | 6 | 0.140 |
Why?
| Thermometers | 1 | 1995 | 6 | 0.140 |
Why?
| Brown-Sequard Syndrome | 1 | 1995 | 5 | 0.140 |
Why?
| Eicosanoids | 1 | 1996 | 55 | 0.140 |
Why?
| Thermography | 1 | 1995 | 13 | 0.140 |
Why?
| Tympanic Membrane | 1 | 1995 | 19 | 0.140 |
Why?
| Autoimmune Diseases | 4 | 2000 | 408 | 0.130 |
Why?
| Cyanoacrylates | 1 | 1995 | 4 | 0.130 |
Why?
| Medical History Taking | 1 | 2015 | 121 | 0.130 |
Why?
| Mountaineering | 3 | 2008 | 49 | 0.130 |
Why?
| HLA Antigens | 5 | 1991 | 230 | 0.130 |
Why?
| Joint Deformities, Acquired | 2 | 2000 | 11 | 0.130 |
Why?
| Tissue Adhesives | 1 | 1995 | 18 | 0.130 |
Why?
| Jews | 5 | 2009 | 19 | 0.130 |
Why?
| Foot Ulcer | 1 | 1995 | 10 | 0.130 |
Why?
| Colitis, Ulcerative | 1 | 1996 | 106 | 0.130 |
Why?
| Hospital Design and Construction | 1 | 1994 | 3 | 0.130 |
Why?
| Lacerations | 1 | 1995 | 28 | 0.130 |
Why?
| HLA-DR Antigens | 2 | 1994 | 228 | 0.130 |
Why?
| Hand Injuries | 1 | 1995 | 38 | 0.130 |
Why?
| Fever | 2 | 1996 | 289 | 0.130 |
Why?
| Creatinine | 3 | 2014 | 510 | 0.130 |
Why?
| Glycosaminoglycans | 2 | 1999 | 81 | 0.130 |
Why?
| Administration, Oral | 3 | 2014 | 786 | 0.130 |
Why?
| Joints | 4 | 2004 | 85 | 0.120 |
Why?
| Wounds, Penetrating | 1 | 1995 | 79 | 0.120 |
Why?
| Hypersensitivity | 1 | 1998 | 259 | 0.120 |
Why?
| Cartilage, Articular | 3 | 2001 | 315 | 0.120 |
Why?
| Recommended Dietary Allowances | 1 | 2014 | 16 | 0.120 |
Why?
| Metacarpophalangeal Joint | 1 | 1993 | 11 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 839 | 0.120 |
Why?
| Androgen-Insensitivity Syndrome | 1 | 2013 | 6 | 0.120 |
Why?
| Amyloidosis | 3 | 1988 | 41 | 0.120 |
Why?
| Environment | 1 | 2015 | 357 | 0.120 |
Why?
| Phosphorus | 1 | 2014 | 85 | 0.120 |
Why?
| Cells, Cultured | 7 | 2003 | 4162 | 0.120 |
Why?
| Parathyroid Hormone | 1 | 2014 | 99 | 0.120 |
Why?
| Reference Values | 4 | 2007 | 789 | 0.110 |
Why?
| Calcitriol | 1 | 1993 | 55 | 0.110 |
Why?
| Healthy Volunteers | 1 | 2014 | 209 | 0.110 |
Why?
| Growth Inhibitors | 1 | 1993 | 44 | 0.110 |
Why?
| Random Allocation | 1 | 2014 | 360 | 0.110 |
Why?
| Colorado | 4 | 2010 | 4325 | 0.110 |
Why?
| Wound Healing | 1 | 1995 | 279 | 0.110 |
Why?
| Blood Sedimentation | 5 | 2000 | 34 | 0.110 |
Why?
| Synovitis | 4 | 1993 | 24 | 0.110 |
Why?
| Child, Preschool | 7 | 2007 | 9755 | 0.110 |
Why?
| Point Mutation | 1 | 2013 | 231 | 0.110 |
Why?
| Acute-Phase Reaction | 2 | 1989 | 39 | 0.110 |
Why?
| Leucovorin | 2 | 1990 | 45 | 0.110 |
Why?
| Prevalence | 3 | 2010 | 2442 | 0.110 |
Why?
| Leukocytes | 4 | 2002 | 295 | 0.110 |
Why?
| Carpal Bones | 1 | 1992 | 14 | 0.110 |
Why?
| Radiography | 7 | 2001 | 888 | 0.110 |
Why?
| Hyperemia | 1 | 1992 | 43 | 0.110 |
Why?
| Ulna | 1 | 1992 | 23 | 0.110 |
Why?
| Receptors, Androgen | 1 | 2013 | 136 | 0.110 |
Why?
| Eye Diseases | 2 | 1992 | 78 | 0.110 |
Why?
| Time Factors | 12 | 2003 | 6682 | 0.110 |
Why?
| Erythema Nodosum | 1 | 1991 | 3 | 0.100 |
Why?
| Measles virus | 2 | 1981 | 11 | 0.100 |
Why?
| Rubella virus | 2 | 1981 | 6 | 0.100 |
Why?
| Vitamin D | 2 | 2014 | 363 | 0.100 |
Why?
| Vasculitis | 3 | 2001 | 75 | 0.100 |
Why?
| Red-Cell Aplasia, Pure | 1 | 1991 | 1 | 0.100 |
Why?
| Spinal Injuries | 1 | 1992 | 54 | 0.100 |
Why?
| Airway Obstruction | 2 | 1996 | 182 | 0.100 |
Why?
| Interleukin-10 | 2 | 2006 | 314 | 0.100 |
Why?
| Microbial Collagenase | 1 | 1990 | 10 | 0.100 |
Why?
| Reproducibility of Results | 3 | 2007 | 2977 | 0.100 |
Why?
| Myocardial Infarction | 2 | 2014 | 1134 | 0.100 |
Why?
| Urinary Tract Infections | 1 | 1992 | 143 | 0.090 |
Why?
| Child | 9 | 2015 | 19561 | 0.090 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 1992 | 141 | 0.090 |
Why?
| Digital Rectal Examination | 1 | 2010 | 10 | 0.090 |
Why?
| Arthritis | 4 | 2000 | 115 | 0.090 |
Why?
| Occult Blood | 1 | 2010 | 27 | 0.090 |
Why?
| Heart Rate | 1 | 2014 | 756 | 0.090 |
Why?
| Treatment Outcome | 10 | 2004 | 9692 | 0.090 |
Why?
| Anti-Bacterial Agents | 5 | 2003 | 1562 | 0.090 |
Why?
| Interferon-gamma | 2 | 1990 | 747 | 0.090 |
Why?
| Receptors, Neurokinin-1 | 1 | 2009 | 13 | 0.090 |
Why?
| Testosterone | 1 | 2013 | 353 | 0.090 |
Why?
| Jaundice | 1 | 1989 | 15 | 0.090 |
Why?
| Diclofenac | 1 | 1989 | 15 | 0.090 |
Why?
| Ligaments, Articular | 1 | 1990 | 57 | 0.090 |
Why?
| Spinal Diseases | 1 | 1990 | 47 | 0.090 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 40 | 0.090 |
Why?
| Intervertebral Disc Displacement | 1 | 1990 | 40 | 0.090 |
Why?
| Temporomandibular Joint Disorders | 1 | 1989 | 10 | 0.090 |
Why?
| Temporomandibular Joint | 1 | 1989 | 12 | 0.090 |
Why?
| Anemia, Aplastic | 1 | 1989 | 30 | 0.090 |
Why?
| Infant | 6 | 2004 | 8523 | 0.090 |
Why?
| Aspirin | 2 | 2003 | 344 | 0.090 |
Why?
| Cryoglobulinemia | 1 | 1988 | 5 | 0.090 |
Why?
| Keratosis | 1 | 1988 | 13 | 0.090 |
Why?
| Familial Mediterranean Fever | 1 | 1988 | 6 | 0.090 |
Why?
| Ichthyosis | 1 | 1988 | 12 | 0.090 |
Why?
| Age Factors | 6 | 2015 | 3114 | 0.080 |
Why?
| Biological Factors | 1 | 1989 | 42 | 0.080 |
Why?
| Auranofin | 1 | 1988 | 9 | 0.080 |
Why?
| Scleroderma, Systemic | 2 | 2000 | 96 | 0.080 |
Why?
| Lipopolysaccharides | 2 | 2003 | 875 | 0.080 |
Why?
| Chyle | 1 | 1988 | 3 | 0.080 |
Why?
| Stomatitis, Aphthous | 1 | 1988 | 10 | 0.080 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 123 | 0.080 |
Why?
| Immunoglobulins | 1 | 1988 | 166 | 0.080 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 1988 | 73 | 0.080 |
Why?
| Seasons | 1 | 2010 | 468 | 0.080 |
Why?
| Interviews as Topic | 1 | 2010 | 601 | 0.080 |
Why?
| Language | 1 | 2010 | 271 | 0.080 |
Why?
| Hydrocortisone | 3 | 2001 | 315 | 0.080 |
Why?
| Ligaments | 1 | 1988 | 48 | 0.080 |
Why?
| Adolescent | 12 | 2015 | 18948 | 0.080 |
Why?
| Peripheral Nervous System Diseases | 1 | 1988 | 126 | 0.080 |
Why?
| Polychondritis, Relapsing | 1 | 1987 | 2 | 0.080 |
Why?
| HLA-B27 Antigen | 1 | 2007 | 12 | 0.080 |
Why?
| Academic Medical Centers | 1 | 2010 | 427 | 0.080 |
Why?
| Double-Blind Method | 3 | 2003 | 1711 | 0.080 |
Why?
| Skin | 5 | 2003 | 694 | 0.070 |
Why?
| Joint Diseases | 1 | 1988 | 63 | 0.070 |
Why?
| Remission Induction | 3 | 1993 | 246 | 0.070 |
Why?
| Edema | 1 | 1988 | 130 | 0.070 |
Why?
| Cysts | 1 | 1988 | 94 | 0.070 |
Why?
| Chronic Disease | 4 | 2015 | 1645 | 0.070 |
Why?
| Demography | 2 | 1999 | 290 | 0.070 |
Why?
| Evaluation Studies as Topic | 3 | 1999 | 190 | 0.070 |
Why?
| Blood Proteins | 1 | 1988 | 249 | 0.070 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2006 | 25 | 0.070 |
Why?
| Liver | 2 | 1992 | 1827 | 0.070 |
Why?
| Spine | 1 | 1988 | 147 | 0.070 |
Why?
| Syndrome | 4 | 1993 | 363 | 0.070 |
Why?
| Diagnosis, Differential | 4 | 2003 | 1423 | 0.070 |
Why?
| Isoxazoles | 1 | 2006 | 56 | 0.070 |
Why?
| Monitoring, Physiologic | 2 | 2004 | 288 | 0.070 |
Why?
| Recombinant Proteins | 3 | 1997 | 1318 | 0.070 |
Why?
| Culture Techniques | 2 | 1999 | 81 | 0.070 |
Why?
| Primary Prevention | 1 | 2008 | 212 | 0.070 |
Why?
| Shoulder Joint | 1 | 1988 | 177 | 0.070 |
Why?
| Oxygen | 3 | 2003 | 887 | 0.070 |
Why?
| Pedigree | 4 | 2000 | 492 | 0.070 |
Why?
| Incidence | 3 | 2002 | 2527 | 0.070 |
Why?
| Rheumatoid Factor | 2 | 2001 | 155 | 0.060 |
Why?
| Sports | 2 | 2015 | 197 | 0.060 |
Why?
| Retrospective Studies | 9 | 2010 | 13433 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2000 | 1174 | 0.060 |
Why?
| Kidney | 2 | 2003 | 1355 | 0.060 |
Why?
| Octreotide | 1 | 2004 | 27 | 0.060 |
Why?
| Oximetry | 2 | 2003 | 96 | 0.060 |
Why?
| Biopsy, Needle | 2 | 1999 | 192 | 0.060 |
Why?
| Cell Division | 4 | 1993 | 788 | 0.060 |
Why?
| Crohn Disease | 2 | 2004 | 200 | 0.060 |
Why?
| Inflammation | 3 | 1989 | 2598 | 0.060 |
Why?
| Autoantibodies | 4 | 1999 | 1353 | 0.060 |
Why?
| Patient Discharge | 1 | 2010 | 842 | 0.060 |
Why?
| Crotonates | 1 | 2003 | 3 | 0.060 |
Why?
| Toluidines | 1 | 2003 | 5 | 0.060 |
Why?
| Tenosynovitis | 1 | 2003 | 12 | 0.060 |
Why?
| Mycobacterium kansasii | 1 | 2003 | 14 | 0.060 |
Why?
| Hypnosis | 1 | 1983 | 10 | 0.060 |
Why?
| Pemphigus | 1 | 1983 | 8 | 0.060 |
Why?
| Tuberculosis, Miliary | 1 | 2003 | 5 | 0.060 |
Why?
| Tuberculosis, Cutaneous | 1 | 2003 | 4 | 0.060 |
Why?
| Acne Vulgaris | 3 | 1998 | 28 | 0.060 |
Why?
| Carpal Tunnel Syndrome | 1 | 2003 | 28 | 0.060 |
Why?
| Fasciitis | 1 | 1982 | 8 | 0.060 |
Why?
| Lip | 2 | 2001 | 22 | 0.060 |
Why?
| Wakefulness | 1 | 2004 | 141 | 0.060 |
Why?
| Lipoproteins | 1 | 1983 | 164 | 0.060 |
Why?
| Follow-Up Studies | 3 | 1999 | 4768 | 0.060 |
Why?
| Tidal Volume | 1 | 2003 | 77 | 0.060 |
Why?
| Technetium Tc 99m Exametazime | 1 | 2002 | 2 | 0.060 |
Why?
| Spondylarthropathies | 1 | 2002 | 6 | 0.050 |
Why?
| History, 20th Century | 1 | 2004 | 288 | 0.050 |
Why?
| Respiratory Function Tests | 2 | 2003 | 563 | 0.050 |
Why?
| Cell Survival | 2 | 2003 | 1075 | 0.050 |
Why?
| Drug Evaluation, Preclinical | 1 | 2003 | 187 | 0.050 |
Why?
| Nitriles | 1 | 2003 | 158 | 0.050 |
Why?
| Arthritis, Experimental | 1 | 2004 | 130 | 0.050 |
Why?
| Radionuclide Imaging | 3 | 2002 | 134 | 0.050 |
Why?
| Osteoporosis, Postmenopausal | 2 | 2000 | 38 | 0.050 |
Why?
| Athletes | 2 | 2015 | 355 | 0.050 |
Why?
| Hepatitis B Vaccines | 1 | 2002 | 48 | 0.050 |
Why?
| Newcastle disease virus | 1 | 1981 | 17 | 0.050 |
Why?
| Biopsy | 2 | 1999 | 1090 | 0.050 |
Why?
| Adenoviruses, Human | 1 | 1981 | 25 | 0.050 |
Why?
| Hepatitis B | 1 | 2002 | 54 | 0.050 |
Why?
| Complement C3b | 1 | 2001 | 32 | 0.050 |
Why?
| Young Adult | 2 | 2015 | 11094 | 0.050 |
Why?
| Family Health | 2 | 1994 | 201 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2009 | 551 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2009 | 2359 | 0.050 |
Why?
| Movement | 1 | 2004 | 257 | 0.050 |
Why?
| fas Receptor | 1 | 2001 | 95 | 0.050 |
Why?
| Immunocompromised Host | 1 | 2003 | 205 | 0.050 |
Why?
| Prednisolone | 2 | 1992 | 76 | 0.050 |
Why?
| Emergencies | 2 | 1996 | 159 | 0.050 |
Why?
| Nitroprusside | 1 | 2001 | 90 | 0.050 |
Why?
| Radiopharmaceuticals | 1 | 2002 | 196 | 0.050 |
Why?
| Hemoglobins | 1 | 2003 | 293 | 0.050 |
Why?
| Gastric Antral Vascular Ectasia | 1 | 2000 | 2 | 0.050 |
Why?
| Carbon Dioxide | 1 | 2003 | 237 | 0.050 |
Why?
| Cerebrovascular Circulation | 1 | 2003 | 208 | 0.050 |
Why?
| Eosinophilia | 1 | 1982 | 177 | 0.050 |
Why?
| Xanthine | 1 | 2000 | 8 | 0.050 |
Why?
| Uric Acid | 2 | 2003 | 354 | 0.050 |
Why?
| Skiing | 1 | 2001 | 39 | 0.050 |
Why?
| United States | 3 | 2008 | 13272 | 0.050 |
Why?
| Salivary Glands | 2 | 1997 | 32 | 0.050 |
Why?
| Xanthine Dehydrogenase | 1 | 2000 | 34 | 0.050 |
Why?
| Monocytes | 2 | 2001 | 523 | 0.050 |
Why?
| Pneumococcal Vaccines | 1 | 2001 | 141 | 0.050 |
Why?
| Sulfur Radioisotopes | 1 | 1999 | 17 | 0.050 |
Why?
| Leg | 2 | 1996 | 249 | 0.050 |
Why?
| Neck Pain | 1 | 2000 | 24 | 0.050 |
Why?
| Haplotypes | 2 | 1992 | 482 | 0.050 |
Why?
| Fractures, Stress | 1 | 2000 | 37 | 0.050 |
Why?
| Lipids | 1 | 1983 | 614 | 0.050 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 1999 | 32 | 0.050 |
Why?
| Anxiety Disorders | 1 | 1983 | 326 | 0.040 |
Why?
| HLA-DR4 Antigen | 2 | 1992 | 75 | 0.040 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 1999 | 37 | 0.040 |
Why?
| DNA, Viral | 1 | 1981 | 358 | 0.040 |
Why?
| Glucocorticoids | 2 | 2001 | 554 | 0.040 |
Why?
| Sialoglycoproteins | 1 | 2000 | 162 | 0.040 |
Why?
| Analysis of Variance | 1 | 2003 | 1329 | 0.040 |
Why?
| Stimulation, Chemical | 2 | 1989 | 61 | 0.040 |
Why?
| Age of Onset | 1 | 2001 | 479 | 0.040 |
Why?
| Xerostomia | 1 | 1999 | 18 | 0.040 |
Why?
| Alkaline Phosphatase | 2 | 1992 | 161 | 0.040 |
Why?
| Indomethacin | 2 | 1989 | 76 | 0.040 |
Why?
| Translations | 1 | 1999 | 16 | 0.040 |
Why?
| Hand Strength | 1 | 2000 | 106 | 0.040 |
Why?
| Sarcoidosis | 1 | 2001 | 132 | 0.040 |
Why?
| Hemiplegia | 1 | 1998 | 19 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 1992 | 757 | 0.040 |
Why?
| Diagnostic Errors | 1 | 2000 | 171 | 0.040 |
Why?
| Immunoglobulins, Intravenous | 1 | 2000 | 130 | 0.040 |
Why?
| Lumbosacral Region | 2 | 1990 | 52 | 0.040 |
Why?
| Recurrence | 2 | 1992 | 998 | 0.040 |
Why?
| Drug Synergism | 2 | 1990 | 346 | 0.040 |
Why?
| Paresis | 1 | 1998 | 32 | 0.040 |
Why?
| Infant Behavior | 1 | 1998 | 35 | 0.040 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2003 | 334 | 0.040 |
Why?
| Appetite | 1 | 1998 | 57 | 0.040 |
Why?
| Immunoglobulin A, Secretory | 1 | 1997 | 12 | 0.040 |
Why?
| Health Status | 2 | 2004 | 758 | 0.040 |
Why?
| RNA, Viral | 1 | 1981 | 597 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 1997 | 48 | 0.040 |
Why?
| Lactoferrin | 1 | 1997 | 30 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2004 | 1306 | 0.040 |
Why?
| Electrolytes | 1 | 1997 | 62 | 0.040 |
Why?
| Polymyalgia Rheumatica | 1 | 1997 | 2 | 0.040 |
Why?
| Prognosis | 2 | 1996 | 3563 | 0.040 |
Why?
| Folic Acid Antagonists | 1 | 1997 | 8 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 1998 | 67 | 0.040 |
Why?
| Cartilage | 1 | 1999 | 196 | 0.040 |
Why?
| Inflammatory Bowel Diseases | 2 | 2002 | 290 | 0.040 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 93 | 0.040 |
Why?
| Appendicitis | 1 | 1998 | 128 | 0.040 |
Why?
| Dermatitis, Allergic Contact | 1 | 1998 | 62 | 0.040 |
Why?
| Forced Expiratory Flow Rates | 1 | 1996 | 15 | 0.040 |
Why?
| Psoriasis | 2 | 2000 | 86 | 0.040 |
Why?
| Gene Frequency | 2 | 2009 | 522 | 0.040 |
Why?
| Histocompatibility Testing | 1 | 1997 | 123 | 0.040 |
Why?
| Drug Hypersensitivity | 1 | 1998 | 82 | 0.040 |
Why?
| Magnetic Resonance Imaging | 3 | 1998 | 3264 | 0.040 |
Why?
| Pain Clinics | 1 | 1996 | 3 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2002 | 1947 | 0.040 |
Why?
| Chiropractic | 1 | 1996 | 6 | 0.040 |
Why?
| Patella | 1 | 1996 | 25 | 0.040 |
Why?
| Thromboxane B2 | 1 | 1996 | 28 | 0.040 |
Why?
| Drug Therapy, Combination | 3 | 2003 | 988 | 0.040 |
Why?
| Cohort Studies | 3 | 1998 | 5294 | 0.040 |
Why?
| Acupuncture Therapy | 1 | 1996 | 19 | 0.030 |
Why?
| Radioimmunoassay | 1 | 1996 | 168 | 0.030 |
Why?
| Menopause | 1 | 1999 | 270 | 0.030 |
Why?
| Ribonucleoproteins | 1 | 1997 | 101 | 0.030 |
Why?
| Mouth Diseases | 1 | 1996 | 38 | 0.030 |
Why?
| Risk Assessment | 2 | 2015 | 3213 | 0.030 |
Why?
| Adrenergic beta-Agonists | 1 | 1996 | 134 | 0.030 |
Why?
| Wilderness Medicine | 1 | 2015 | 16 | 0.030 |
Why?
| Pilot Projects | 2 | 2004 | 1477 | 0.030 |
Why?
| Risk Factors | 4 | 2015 | 9381 | 0.030 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1995 | 22 | 0.030 |
Why?
| Poliomyelitis | 1 | 1995 | 27 | 0.030 |
Why?
| Thrombophlebitis | 1 | 1995 | 8 | 0.030 |
Why?
| Abdomen | 2 | 2002 | 117 | 0.030 |
Why?
| Maintenance and Engineering, Hospital | 1 | 1994 | 2 | 0.030 |
Why?
| Reference Standards | 1 | 1995 | 177 | 0.030 |
Why?
| Mutation | 2 | 2009 | 3493 | 0.030 |
Why?
| Macrophages | 1 | 2001 | 1334 | 0.030 |
Why?
| Rectum | 1 | 1995 | 158 | 0.030 |
Why?
| Antibodies, Antineutrophil Cytoplasmic | 3 | 1999 | 35 | 0.030 |
Why?
| Cholesterol | 2 | 1988 | 380 | 0.030 |
Why?
| Angiography | 1 | 1995 | 193 | 0.030 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1993 | 2 | 0.030 |
Why?
| Blotting, Western | 1 | 1997 | 1225 | 0.030 |
Why?
| Autoantigens | 1 | 1997 | 407 | 0.030 |
Why?
| Semen Analysis | 1 | 2013 | 10 | 0.030 |
Why?
| Sperm Count | 1 | 2013 | 17 | 0.030 |
Why?
| Sperm Injections, Intracytoplasmic | 1 | 2013 | 8 | 0.030 |
Why?
| Parents | 1 | 2002 | 1256 | 0.030 |
Why?
| Food Hypersensitivity | 1 | 1998 | 255 | 0.030 |
Why?
| Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.030 |
Why?
| Ischemia | 1 | 1996 | 382 | 0.030 |
Why?
| Analgesics | 1 | 1995 | 163 | 0.030 |
Why?
| Pregnancy | 3 | 2015 | 5854 | 0.030 |
Why?
| Infertility, Male | 1 | 2013 | 62 | 0.030 |
Why?
| Collagenases | 1 | 1993 | 22 | 0.030 |
Why?
| Rats | 3 | 2004 | 5426 | 0.030 |
Why?
| Linear Models | 1 | 1995 | 854 | 0.030 |
Why?
| Cervical Atlas | 1 | 1992 | 6 | 0.030 |
Why?
| Axis, Cervical Vertebra | 1 | 1992 | 9 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2013 | 278 | 0.030 |
Why?
| Sleep | 1 | 1998 | 722 | 0.030 |
Why?
| Respiratory Tract Diseases | 1 | 1993 | 140 | 0.030 |
Why?
| Radius | 1 | 1992 | 31 | 0.030 |
Why?
| Transaminases | 1 | 1992 | 26 | 0.030 |
Why?
| Blood Urea Nitrogen | 2 | 2003 | 60 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 1995 | 705 | 0.030 |
Why?
| Atmosphere Exposure Chambers | 1 | 1991 | 7 | 0.030 |
Why?
| Apoptosis | 1 | 2001 | 2532 | 0.030 |
Why?
| Collagen | 2 | 1991 | 436 | 0.030 |
Why?
| Serotyping | 1 | 1991 | 33 | 0.030 |
Why?
| Hyperbaric Oxygenation | 1 | 1991 | 42 | 0.030 |
Why?
| Kidney Function Tests | 2 | 2003 | 166 | 0.030 |
Why?
| Pain | 2 | 2001 | 746 | 0.030 |
Why?
| Infant, Premature | 1 | 1995 | 507 | 0.020 |
Why?
| Drug Antagonism | 1 | 1990 | 8 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 1995 | 510 | 0.020 |
Why?
| Logistic Models | 1 | 1996 | 1995 | 0.020 |
Why?
| Crystallization | 2 | 1988 | 148 | 0.020 |
Why?
| Dyspnea | 1 | 1992 | 214 | 0.020 |
Why?
| Disease Models, Animal | 2 | 2004 | 3799 | 0.020 |
Why?
| Anticoagulants | 1 | 1995 | 589 | 0.020 |
Why?
| Antibody Formation | 3 | 2002 | 285 | 0.020 |
Why?
| Self Concept | 1 | 1991 | 221 | 0.020 |
Why?
| Spinal Stenosis | 1 | 1990 | 27 | 0.020 |
Why?
| Drug Combinations | 1 | 1990 | 292 | 0.020 |
Why?
| Etidronic Acid | 2 | 1999 | 3 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 1995 | 2501 | 0.020 |
Why?
| Mandibular Condyle | 1 | 1989 | 5 | 0.020 |
Why?
| Asthma | 3 | 2003 | 2130 | 0.020 |
Why?
| Injections, Intravenous | 1 | 1989 | 217 | 0.020 |
Why?
| Congo Red | 1 | 1988 | 9 | 0.020 |
Why?
| Raynaud Disease | 1 | 1988 | 6 | 0.020 |
Why?
| Accidents | 1 | 1989 | 45 | 0.020 |
Why?
| Smoking | 1 | 1996 | 1556 | 0.020 |
Why?
| HLA-A Antigens | 2 | 1993 | 52 | 0.020 |
Why?
| HLA-B35 Antigen | 1 | 1988 | 3 | 0.020 |
Why?
| Azathioprine | 2 | 1992 | 55 | 0.020 |
Why?
| Infant, Newborn | 3 | 2013 | 5430 | 0.020 |
Why?
| Periarthritis | 1 | 1988 | 1 | 0.020 |
Why?
| Staining and Labeling | 1 | 1988 | 159 | 0.020 |
Why?
| Serum Amyloid P-Component | 1 | 1987 | 4 | 0.020 |
Why?
| Calcium Phosphates | 1 | 1988 | 26 | 0.020 |
Why?
| Point-of-Care Systems | 1 | 2010 | 162 | 0.020 |
Why?
| Immunoglobulin G | 2 | 2001 | 804 | 0.020 |
Why?
| Coronary Disease | 2 | 1995 | 372 | 0.020 |
Why?
| Complement C4 | 1 | 1987 | 26 | 0.020 |
Why?
| Population | 1 | 2007 | 30 | 0.020 |
Why?
| Vaccination | 1 | 1995 | 1241 | 0.020 |
Why?
| Accidental Falls | 1 | 1989 | 157 | 0.020 |
Why?
| Alleles | 1 | 2009 | 852 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 1043 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 1988 | 243 | 0.020 |
Why?
| Hereditary Sensory and Autonomic Neuropathies | 1 | 1985 | 3 | 0.020 |
Why?
| Aging | 1 | 2015 | 1694 | 0.020 |
Why?
| Iran | 2 | 2000 | 81 | 0.020 |
Why?
| Radiography, Thoracic | 1 | 1986 | 168 | 0.020 |
Why?
| Pyoderma Gangrenosum | 1 | 2004 | 4 | 0.020 |
Why?
| Cytokines | 2 | 1990 | 1928 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2004 | 87 | 0.020 |
Why?
| Adipose Tissue | 1 | 1988 | 616 | 0.020 |
Why?
| Infliximab | 1 | 2004 | 95 | 0.020 |
Why?
| Injections, Intramuscular | 1 | 2004 | 127 | 0.010 |
Why?
| Animals | 6 | 2004 | 34133 | 0.010 |
Why?
| Bone Marrow Examination | 1 | 1982 | 7 | 0.010 |
Why?
| Debridement | 1 | 2003 | 78 | 0.010 |
Why?
| Hypergammaglobulinemia | 1 | 1982 | 9 | 0.010 |
Why?
| T-Lymphocytes | 1 | 1991 | 1814 | 0.010 |
Why?
| Splenomegaly | 1 | 1982 | 17 | 0.010 |
Why?
| Finger Joint | 1 | 1982 | 7 | 0.010 |
Why?
| Measles Vaccine | 1 | 1982 | 18 | 0.010 |
Why?
| Hepatitis B Antibodies | 1 | 2002 | 10 | 0.010 |
Why?
| Hepatitis B Surface Antigens | 1 | 2002 | 19 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1376 | 0.010 |
Why?
| Proteinuria | 1 | 1982 | 98 | 0.010 |
Why?
| Myositis | 1 | 1982 | 41 | 0.010 |
Why?
| Serologic Tests | 1 | 2002 | 56 | 0.010 |
Why?
| Measles | 1 | 1982 | 42 | 0.010 |
Why?
| Elbow Joint | 1 | 1982 | 61 | 0.010 |
Why?
| Phospholipids | 1 | 1983 | 211 | 0.010 |
Why?
| Arthritis, Infectious | 1 | 1982 | 52 | 0.010 |
Why?
| Opsonin Proteins | 1 | 2001 | 26 | 0.010 |
Why?
| Chemotherapy, Adjuvant | 1 | 2003 | 369 | 0.010 |
Why?
| Chondrocalcinosis | 1 | 2001 | 2 | 0.010 |
Why?
| Disease Susceptibility | 1 | 1983 | 343 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 2127 | 0.010 |
Why?
| Clinical Chemistry Tests | 1 | 2001 | 11 | 0.010 |
Why?
| Triglycerides | 1 | 1983 | 527 | 0.010 |
Why?
| Receptors, Complement | 1 | 2001 | 118 | 0.010 |
Why?
| Occupations | 1 | 2001 | 39 | 0.010 |
Why?
| Hematologic Tests | 1 | 2001 | 24 | 0.010 |
Why?
| Anemia, Hypochromic | 1 | 2000 | 3 | 0.010 |
Why?
| Therapeutic Equivalency | 1 | 2000 | 17 | 0.010 |
Why?
| Thyroid Diseases | 1 | 2001 | 32 | 0.010 |
Why?
| Antibodies, Bacterial | 1 | 2001 | 129 | 0.010 |
Why?
| Reoperation | 1 | 2003 | 570 | 0.010 |
Why?
| Pneumococcal Infections | 1 | 2001 | 99 | 0.010 |
Why?
| Ankle Joint | 1 | 1982 | 170 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 32 | 0.010 |
Why?
| Thymus Gland | 1 | 2001 | 308 | 0.010 |
Why?
| Histocompatibility Antigens Class II | 1 | 1982 | 397 | 0.010 |
Why?
| Laser Coagulation | 1 | 2000 | 58 | 0.010 |
Why?
| Placebos | 1 | 2000 | 204 | 0.010 |
Why?
| Amino Acid Sequence | 2 | 2000 | 2123 | 0.010 |
Why?
| Furosemide | 1 | 2000 | 34 | 0.010 |
Why?
| Microsatellite Repeats | 1 | 2000 | 147 | 0.010 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2000 | 113 | 0.010 |
Why?
| Diuretics | 1 | 2000 | 78 | 0.010 |
Why?
| Folic Acid | 2 | 1990 | 165 | 0.010 |
Why?
| Serum Sickness | 1 | 1999 | 6 | 0.010 |
Why?
| Genetic Linkage | 1 | 2000 | 328 | 0.010 |
Why?
| Endoscopy, Digestive System | 1 | 2000 | 114 | 0.010 |
Why?
| Antibodies, Anticardiolipin | 1 | 1998 | 5 | 0.010 |
Why?
| Calcitonin | 1 | 1999 | 28 | 0.010 |
Why?
| Hepatitis, Autoimmune | 1 | 1999 | 34 | 0.010 |
Why?
| Serum Albumin | 1 | 2000 | 151 | 0.010 |
Why?
| Iatrogenic Disease | 1 | 1999 | 53 | 0.010 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2000 | 256 | 0.010 |
Why?
| Gene Expression | 1 | 2004 | 1506 | 0.010 |
Why?
| Neoplasms | 1 | 1993 | 2235 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 2000 | 547 | 0.010 |
Why?
| Appendectomy | 1 | 1998 | 75 | 0.010 |
Why?
| Arthralgia | 1 | 1998 | 56 | 0.010 |
Why?
| Estrogen Replacement Therapy | 1 | 1999 | 118 | 0.010 |
Why?
| Kinetics | 1 | 2001 | 1658 | 0.010 |
Why?
| Cell Aggregation | 2 | 1988 | 21 | 0.010 |
Why?
| Laparotomy | 1 | 1998 | 109 | 0.010 |
Why?
| Functional Laterality | 1 | 1998 | 215 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2000 | 345 | 0.010 |
Why?
| Sacroiliac Joint | 1 | 1997 | 34 | 0.010 |
Why?
| Occupational Diseases | 1 | 1998 | 143 | 0.010 |
Why?
| Skin Diseases, Vascular | 1 | 1996 | 8 | 0.010 |
Why?
| Peroxidase | 1 | 1996 | 182 | 0.010 |
Why?
| RNA, Messenger | 1 | 2004 | 2720 | 0.010 |
Why?
| Base Sequence | 1 | 2000 | 2186 | 0.010 |
Why?
| Case-Control Studies | 1 | 2003 | 3296 | 0.010 |
Why?
| Infant Welfare | 1 | 1995 | 4 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 1860 | 0.010 |
Why?
| Bone Density | 1 | 1999 | 451 | 0.010 |
Why?
| Vaccines, Inactivated | 1 | 1995 | 68 | 0.010 |
Why?
| Spirometry | 1 | 1995 | 291 | 0.010 |
Why?
| Europe | 1 | 1994 | 369 | 0.010 |
Why?
| Body Mass Index | 1 | 2000 | 2144 | 0.010 |
Why?
| Osteomyelitis | 1 | 1993 | 110 | 0.010 |
Why?
| Necrosis | 1 | 1972 | 238 | 0.010 |
Why?
| Endopeptidases | 1 | 1990 | 73 | 0.010 |
Why?
| Prostheses and Implants | 1 | 1972 | 145 | 0.010 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1991 | 133 | 0.010 |
Why?
| Lymphoma | 1 | 1990 | 185 | 0.010 |
Why?
| Depression, Chemical | 1 | 1989 | 24 | 0.010 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2003 | 2221 | 0.010 |
Why?
| Drug Interactions | 1 | 1990 | 356 | 0.010 |
Why?
| Interleukin-2 | 1 | 1990 | 420 | 0.010 |
Why?
| Immunity, Cellular | 1 | 1990 | 276 | 0.010 |
Why?
| Health Promotion | 1 | 1995 | 707 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1990 | 904 | 0.010 |
Why?
| Multiple Trauma | 1 | 1989 | 98 | 0.010 |
Why?
| Mice | 3 | 1990 | 15888 | 0.010 |
Why?
| Arthrography | 1 | 1988 | 22 | 0.010 |
Why?
| Lung Diseases | 1 | 1995 | 764 | 0.000 |
Why?
| Injections, Subcutaneous | 1 | 1987 | 137 | 0.000 |
Why?
| Iodine Radioisotopes | 1 | 1987 | 128 | 0.000 |
Why?
| Tissue Distribution | 1 | 1987 | 339 | 0.000 |
Why?
| Hemodynamics | 1 | 1991 | 1036 | 0.000 |
Why?
| Cell Adhesion | 1 | 1988 | 454 | 0.000 |
Why?
| Suicide, Attempted | 1 | 1989 | 331 | 0.000 |
Why?
| Hypertension | 1 | 1995 | 1245 | 0.000 |
Why?
| Poland | 1 | 1985 | 29 | 0.000 |
Why?
| Bacterial Infections | 1 | 1987 | 234 | 0.000 |
Why?
| Virus Diseases | 1 | 1987 | 201 | 0.000 |
Why?
| Vitreous Body | 1 | 1985 | 104 | 0.000 |
Why?
| Amyloid | 1 | 1985 | 89 | 0.000 |
Why?
| Preoperative Care | 1 | 1986 | 342 | 0.000 |
Why?
| HLA-DR1 Antigen | 1 | 1982 | 1 | 0.000 |
Why?
| Tuberculosis | 1 | 1986 | 266 | 0.000 |
Why?
| Rats, Inbred Strains | 1 | 1982 | 392 | 0.000 |
Why?
| Injections, Intra-Articular | 1 | 1982 | 63 | 0.000 |
Why?
| Lung Neoplasms | 1 | 1986 | 2216 | 0.000 |
Why?
| Methods | 1 | 1972 | 67 | 0.000 |
Why?
| Knee | 1 | 1972 | 55 | 0.000 |
Why?
|
|
Yaron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|